Ambulatory Cancer Care Centers (CAOPs)

Cancer treatment

Main article: Cancer treatment

2022: The Ministry of Health reported on the opening of 90% of outpatient cancer care centers

By December 12, 2022, 90% of outpatient oncological care centers (CAOP) were built in Russia out of 500 facilities planned for launch within the framework of the federal project "Combating Cancer." Such data were provided by the Minister of Health of the Russian Federation Mikhail Murashko.

According to the passport of this fedproject, 467 CAOPs should be built by the end of 2022, and 540 centers by the end of 2024. According to the publication "Medical Bulletin," in some subjects TsAOP were launched "for show" at oncological dispensaries, and others did not have enough money and personnel for this undertaking.

The Ministry of Health reported on the opening of outpatient cancer care centers

Earlier, the Ministry of Health determined a list of criteria for inspections of the activities of the Central Administrative District, according to which the executive authorities of the subjects in the field of health protection were recommended to evaluate their work. Including it included: an assortment of used chemotherapy drug regimens, including the cost of drugs, the workload of medical equipment and "assessing the sufficiency of the studies conducted to the needs of patients." Verification measures were prescribed to be carried out jointly with the oncological dispensary, the main freelance oncologist and the main freelance chemotherapist (if any) of the subjects.

In the summer of 2022, oncologists asked to adjust the tariffs for payment for therapy at the Central Administrative District: they explained that the current compulsory medical insurance standard, according to which outpatient oncological care centers are funded, does not take into account epidemiological data and the use of new anticancer drugs. According to the monitoring of the implementation of a specialized federal project, in 2020, the variety of anti-tumor drug therapy regimens in the Central Administrative District was calculated as five to six positions. Thus, only 5% of the therapy guaranteed in the compulsory medical insurance was available to patients of such centers.^[1]

2021: 408.9 thousand chemotherapies were carried out at outpatient cancer care centers

Throughout 2021, 408,924 hospitalizations were registered in Russian centers for outpatient oncological care (CAOP) for conducting. chemotherapy Such data at the end of January 2022 was published by the deputy head, Ministry of Health of the Russian Federation Evgeny Kamkin speaking at a round table in. In To the State Duma 2020, according to calculations, Rosstat 148.3 thousand people underwent chemotherapy at the Central Administrative District against 32.1 thousand in 2019.

According to Kamkin, by the end of 2021, there were 405 CAOPs in Russia in 77 regions of the country, 125 of them opened in 2021. Over the year, 155.6 thousand cases of cancer were detected in the Central Administrative District, which is a third of all specialized diagnoses made in Russia for the first time, and 59.4% of them had stage I-II of the disease. In total, the centers in 2021 served 2.2 million people (3.7 million visits).

In the centers of outpatient cancer care conducted 408.9 thousand chemotherapy

Most of the patients who underwent chemotherapy in the CAOP had breast cancer, fewer had prostate cancer and colorectal cancer. Most often (in 8.1% of cases), the drug therapy regimen with goserelin was used (used in CSH level 1), in 4.1% - fulvestrant (level 4), 4% - trastuzumab (level 5). In 2020, according to Rosstat, 148.3 thousand people underwent chemotherapy at the Central Administrative District against 32.1 thousand in 2019.

During the implementation of the federal project "Combating Cancer" in Russia, 214 regional and 60 federal medical organizations were re-equipped, 3 proton beam therapy centers were put into operation, 18 reference centers were organized.

Of course, the greatest concern is the indicator of early detection of malignancies. This indicator is directly affected by the consequences of the imposed restrictions associated with the spread of a new coronavirus infection. There is an increase in the proportion of patients with cancer detected at advanced stages, "Kamkin said.[2]

Notes